Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients

Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer

(2019) Bingyi Yang et al.   GYNECOLOGIC ONCOLOGY

Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients

(2018) Bingyi Yang et al.   Journal of Gynecologic Oncology

Early menarche, nulliparity and the risk for premature and early natural menopause

(2017) Gita D. Mishra et al.   HUMAN REPRODUCTION

Obesity Statistics

(2016) Kristy Breuhl Smith et al.   PRIMARY CARE

Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients

(2015) Rong Zhou et al.   GYNECOLOGIC ONCOLOGY

Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer

(2015) Ming Chen et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: A prospective cross-sectional study

(2014) Weiwei Shan et al.   GYNECOLOGIC ONCOLOGY

Endometrial metaplasias and reactive changes: a spectrum of altered differentiation

(2010) A. Nicolae et al.   JOURNAL OF CLINICAL PATHOLOGY

Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change

(2008) J W Carlson et al.   HISTOPATHOLOGY

Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2

(2008) O Houghton et al.   HISTOPATHOLOGY